Vertex Pharmaceuticals Incorporated VRTX
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Danielle Brill | Truist Financial | 435.93 $ | 542 $ | 106.07 % | 27/05/2026 |
| Brian Abrahams | RBC Capital | 429.85 $ | 543 $ | 113.15 % | 05/05/2026 |
| Joon Lee | Truist Financial | 499.14 $ | 525 $ | 25.86 % | 10/03/2026 |
| Akash Tewari | Jefferies | 496.5 $ | 580 $ | 83.50 % | 10/03/2026 |
| Evan David Seigerman | BMO Capital | 487.57 $ | 600 $ | 112.43 % | 02/03/2026 |
| Eliana Merle | Barclays | 491.47 $ | 607 $ | 115.53 % | 17/02/2026 |
| Andrew Fein | H.C. Wainwright | 491.47 $ | 591 $ | 99.53 % | 17/02/2026 |
| Terence Flynn | Morgan Stanley | 497.42 $ | 570 $ | 72.58 % | 13/02/2026 |
| Louise Chen | Scotiabank | 493.98 $ | 558 $ | 64.02 % | 13/02/2026 |
| Paul Matteis | Stifel Nicolaus | 465.02 $ | 466 $ | 0.98 % | 13/02/2026 |
| Andrew Fein | H.C. Wainwright | 465.02 $ | 518 $ | 52.98 % | 13/02/2026 |
| Cory Kasimov | Evercore ISI | 469.11 $ | 530 $ | 60.89 % | 23/01/2026 |
| Brian Abrahams | RBC Capital | 461.14 $ | 546 $ | 84.86 % | 22/01/2026 |
| Michael Yee | UBS | 468.38 $ | 535 $ | 66.62 % | 06/01/2026 |
| Terence Flynn | Morgan Stanley | 433.15 $ | 516 $ | 82.85 % | 03/12/2025 |
| Carter Gould | Cantor Fitzgerald | 427.2999 $ | 485 $ | 57.70 % | 04/11/2025 |
| Gena Wang | Barclays | 426 $ | 414 $ | -12.00 % | 04/11/2025 |
| Eliana Merle | UBS | 374.98 $ | 553 $ | 178.02 % | 05/08/2025 |
| Brian Abrahams | RBC Capital | 441.99 $ | 420 $ | -21.99 % | 17/06/2025 |
| Greg Harrison | Scotiabank | 450.03 $ | 442 $ | -8.03 % | 06/05/2025 |
| Evan Seigerman | BMO Capital | 461.68 $ | 545 $ | 83.32 % | 31/01/2025 |
| Mohit Bansal | Wells Fargo | 441.52 $ | 460 $ | 18.48 % | 30/01/2025 |
| Terence Flynn | Morgan Stanley | 409.56 $ | 456 $ | 46.44 % | 10/01/2025 |
| Brian Abrahams | RBC Capital | 469.22 $ | 400 $ | -69.22 % | 19/12/2024 |
| Michael Yee | Jefferies | 462.1 $ | 550 $ | 87.90 % | 09/12/2024 |
| Hartaj Singh | Oppenheimer | 499.1004 $ | 540 $ | 40.90 % | 05/11/2024 |
| Brian Abrahams | RBC Capital | 499.88 $ | 451 $ | -48.88 % | 05/11/2024 |
| Whitney Ijem | Canaccord Genuity | 478.09 $ | 361 $ | -117.09 % | 22/10/2024 |
| Evan David Seigerman | BMO Capital | 485.74 $ | 566 $ | 80.26 % | 21/10/2024 |
| Salveen Richter | Goldman Sachs | 483 $ | 598 $ | 115.00 % | 21/10/2024 |
| Geoff Meacham | Bank of America Securities | 482.115 $ | 541 $ | 58.89 % | 14/10/2024 |
| Brian Abrahams | RBC Capital | 458.94 $ | 437 $ | -21.94 % | 09/10/2024 |
| Joon Lee | Truist Financial | 494.46 $ | 550 $ | 55.54 % | 05/08/2024 |
| Hartaj Singh | Oppenheimer | 477.86 $ | 550 $ | 72.14 % | 05/08/2024 |
| Andy Chen | Wolfe Research | 476.91 $ | 576 $ | 99.09 % | 05/08/2024 |
| Andrew Fein | H.C. Wainwright | 505.78 $ | 600 $ | 94.22 % | 02/08/2024 |
| Jasper Hellweg | Argus Research | 474.61 $ | 550 $ | 75.39 % | 17/06/2024 |
| Brian Abrahams | RBC Capital | 483.28 $ | 421 $ | -62.28 % | 11/06/2024 |
| Evan David Seigerman | BMO Capital | 443.05 $ | 500 $ | 56.95 % | 31/05/2024 |
| Christopher Raymond | Raymond James | 413.42 $ | 456 $ | 42.58 % | 07/05/2024 |
| Brian Abrahams | RBC Capital | 402.5 $ | 424 $ | 21.50 % | 07/05/2024 |
| Andrew Fein | H.C. Wainwright | 397.58 $ | 462 $ | 64.42 % | 11/04/2024 |
| Liisa Bayko | Evercore ISI | 397.58 $ | 438 $ | 40.42 % | 11/04/2024 |
| Olivia Brayer | Cantor Fitzgerald | 290.01 $ | 365 $ | 74.99 % | 12/07/2022 |
| Paul Matteis | Stifel Nicolaus | 295.46 $ | 240 $ | -55.46 % | 11/07/2022 |
| Jasper Hellweg | Argus Research | 287.32 $ | 280 $ | -7.32 % | 02/07/2022 |
| Matthew Harrison | Morgan Stanley | 261.96 $ | 250 $ | -11.96 % | 03/05/2022 |
| Hartaj Singh | Oppenheimer | 272.39 $ | 350 $ | 77.61 % | 06/04/2022 |
| Brian Skorney | Robert W. Baird | 251.88 $ | 240 $ | -11.88 % | 22/03/2022 |
| Evan Seigerman | BMO Capital | 251.88 $ | 274 $ | 22.12 % | 22/03/2022 |
| Michael Yee | Jefferies | 228.22 $ | 275 $ | 46.78 % | 27/01/2022 |
| Cory Kasimov | J.P. Morgan | 228.22 $ | 288 $ | 59.78 % | 27/01/2022 |
| Matthew Harrison | Morgan Stanley | 228.22 $ | 208 $ | -20.22 % | 27/01/2022 |
| Andrew Galler | Wolfe Research | 228.22 $ | 282 $ | 53.78 % | 27/01/2022 |
| Phil Nadeau | Cowen & Co. | 229.68 $ | 300 $ | 70.32 % | 24/01/2022 |
| Geoff Porges | Leerink Partners | 204.45 $ | 175 $ | -29.45 % | 02/12/2021 |
| Debjit Chattopadhyay | Guggenheim | 205 $ | 286 $ | 81.00 % | 01/12/2021 |
| Geoff Meacham | Bank of America Securities | 181.4 $ | 275 $ | 93.60 % | 02/11/2021 |
| Gena Wang | Barclays | 193.02 $ | 285 $ | 91.98 % | 11/06/2021 |
| Alethia Young | Cantor Fitzgerald | 193.02 $ | 281 $ | 87.98 % | 11/06/2021 |
| Colin Bristow | UBS | 212.68 $ | 279 $ | 66.32 % | 12/05/2021 |